MicroRNA Market to hit US$ 846.33 Million by 2030 | Exclusive Report by Growth Plus Reports
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global microRNA market is expected to clock US$ 846.33 million by 2030 and to grow at a CAGR of 13.8% during the forecast period. Owing to the increased prevalence of chronic conditions and extensive product launches. This exclusive information is published by Growth Plus Reports in its report titled "MicroRNA Market – Global Outlook & Forecast 2022-2030".
Factors driving the growth of the microRNA market include the rising prevalence of chronic diseases, rising product launches, and advances and adoption of next-generation sequencing methods, in various areas. Their application and increased acceptance as biomarkers tend to drive the market globally.
The global microRNA market has been analyzed from four different perspectives – product, application, end-user, and region.
Download PDF Brochure of microRNA Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/microrna-market/7783
MicroRNA Market Report Scope & Strategic Insights:
Market Size Value
US$ 264.4 million in 2021
Market Size Value
US$ 846.33 million by 2030
CAGR of 13.8% from 2022 to 2030
Historical data available
Product, Application, End-User, And Region
North America, Europe, Asia Pacific, and the Rest of the World (ROW)
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Excerpts from 'By Product Segmentation'
The global microRNA market has been segmented into two product types: instruments, and reagents and kits. It has been analyzed that the reagents and kits segment dominate the microRNA market because of their increased application in molecular diagnostics due to increased disease prevalence. Also, extensive product launches by various key players Qiagen's molecular diagnostic kit for RNA sequencing drives the market growth.
Excerpts from 'By End-User Segmentation'
The academic and government research institutes segment dominates the microRNA market. Government support initiatives to promote genomics research by academic and research institutes attributes to the segment growth. The growing importance of microRNA for the diagnosis of several diseases such as cancer, cardiovascular diseases, and infectious diseases by diagnostic labs, CROs, and hospitals is also set to contribute to market growth.
Biotechnology and pharmaceutical companies segment is expected to witness a high growth rate because of the continuous product development. Regulus Therapeutics, Mirna Therapeutics, and miRagen Therapeutics are extensively getting involved in the development of RNA-based therapeutics contributing to the growth of the microRNA market.
Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/microrna-market/7783
Excerpts from 'By Region Segmentation'
The global dental caries detectors market microRNA market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global microRNA (miRNA) market, with the largest revenue share in 2021. Growth in the region can be attributed to several factors, including the presence of key players, such as Illumina Inc., rising research and development spending by companies such as Thermo Fisher Scientific to develop innovative and advanced products in the United States expected to drive growth in the region. For example, in March 2021, DiamiR agreed to acquire a CLIA (Clinical Laboratory Improvement Amendments) accredited lab in New Haven, Connecticut from Interpace Biosciences. This will enhance DiamiR's ability to develop and commercialize microRNA-based assays for early detection, differential diagnosis, prediction of progression, and monitoring of brain health and other diseases. Therefore, increasing numbers of cancer cases, new product launches, and increasing product approvals are expected to boost the growth of the microRNA market in the region.
Europe ranks second in the global microRNA market. The increased research funding in the developed European nations like Germany for molecular diagnostic startup entrance in the market is propelling the microRNA market growth. Significant growth is expected in Asia Pacific region. This growth is primarily due to the rapid progress of genomic research and the introduction of new tools to support research activities.
Excerpts from 'Competitive Landscape'
Some of the prominent players operating in the global microRNA market are
- Merck KGaA
- QIAGEN N.V
- Thermo Fisher Scientific, Inc
- GeneCopoeia, Inc
- BioVendor – Laboratorni medicina A.S
- NanoString Technologies, Inc
- Takara Bio Inc
- LGC Limited
- SeqMatic LLC
- Biodynamics Laboratory, Inc
- ORIGENE TECHNOLOGIES, INC
- Among others
Table of Content
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trend (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- GLOBAL MICRORNA MARKET - ANALYSIS & FORECAST, BY PRODUCT
- Reagents & Kits
- GLOBAL MICRORNA MARKET - ANALYSIS & FORECAST, BY APPLICATION
- Disease Diagnostics
- Profiling, Localization, & Quantification
- Isolation & Purification
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Directly Purchase Premium Copy of microRNA Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=JQocSBxNPnOj8TrPxIbtziu3SQBVgW8bEV7cdV78&report_id=7783&license=Single
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
SOURCE Growth Plus Reports
Upcoming Life Sciences Events
- December 2022
- Hong Kong: BIOHK2022
- January 2023
- Biotech Showcase™
- San Francisco: Redefining Early Stage Investments (RESI)